Teladoc Health TDOC Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%-1.2pp | 69.5%-1.3pp | 69.8%-1.0pp | 70.3%-0.5pp | 70.5%-0.3pp | |
| Operating margin | -8.1%+33.2pp | -10.4%+29.3pp | -10.9%+28.0pp | -10.5%+28.9pp | -41.3%-31.4pp | |
| Net margin | -6.8%+32.9pp | -7.9%+31.0pp | -8.8%+29.1pp | -8.2%+30.4pp | -39.7%-30.8pp | |
| Returns | ||||||
| Return on equity | -12.4%+42.1pp | -13.9%+38.5pp | -15.4%+36.2pp | -14.2%+38.8pp | -54.5%-44.3pp | |
| Return on invested capital | -28%+73.8pp | -36.6%+63.4pp | -34.9%+57.9pp | -31.1%+57.4pp | -101.9%-82.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.7×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.8×+1.1× | 2.8×+1.0× | 2.7×+1.0× | 2.7×+1.0× | 1.7×-2.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×-0.4× | 0×-0.4× | 0×-0.4× | 0×-0.4× | 0.4×+0.4× | |
| Net debt / EBITDA | -4.7×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $7.46-9.0% | $7.86-10.1% | $7.87-10.5% | $8.08-8.4% | $8.19-40.0% | |
| Valuation | ||||||
| Market capitalization | $1.41B+16.5% | $1.24B-20.6% | $1.37B-12.6% | $1.4B-14.4% | $1.38B-45.4% | |
| Price / sales | 0.6×+0.1× | 0.5×-0.1× | 0.5×-0.1× | 0.6×-0.1× | 0.5×-0.4× | |
| Price / book | 1.1×+0.2× | 0.9×-0.2× | 1×-0.1× | 1×-0.1× | 1×-0.1× | |
| EV / EBITDA | 4.6×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Teladoc Health's profit margins?
- Teladoc Health (TDOC) runs a 69.3% gross margin and a -8.1% operating margin, with a -6.8% net margin.
- Where do Teladoc Health's ratios come from?
- Every ratio is computed from Teladoc Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
